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ABSTRACT OF DISSERTATION

A CONTROLLED COMPARISON OF
EMOTIONAL REACTIVITY AND PHYSIOLOGICAL
RESPONSE IN CHRONIC OROFACIAL PAIN PATIENTS

This study examined the emotional and physiological differences between
masticatory muscle pain patients and age, height, and weight matched pain-free controls.
Physiological activation and emotional reactivity were assessed in the 22 muscle pain
patients and 23 pain-free controls during a baseline rest period, while discussing a
personally relevant stressor, and during a post-stressor recovery period. Physiological
activity was assessed through the use of the frequency domain heart rate variability
indices. Activity in the high frequency heart rate variability range is an index of
parasympathetic activity while activity in the low frequency heart rate variability range is
an index of both sympathetic and parasympathetic activity (Akselrod, 1981). The muscle
pain patients showed significantly more physiological activation during both the baseline
rest and the post-stressor recovery periods. These physiological differences were
quantified by higher low frequency heart rate variability and lower high frequency heart
rate variability during these study periods. This pattern of higher activation was also
present in the report of emotional reactivity in the muscle pain patients. The emotional
and physiological differences between the groups across study periods were more
pronounced in muscle pain patients who reported a traumatic life experience. These
results provide evidence of physiological activation and emotional responding in
masticatory muscle pain patients that differentiates them from matched pain-free
controls. The use of HRV indices to measure physiological functioning quantifies the
degree of sympathetic and parasympathetic activation. Study results suggest the use of
these HRV indices will improve understanding of the role that excitatory and inhibitory
mechanisms play in the onset and maintenance of chronic masticatory muscle pain
conditions.
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Chapter One
Introduction
Background
Orofacial pain occurs within the umbrella of Temporomandibular Disorders
(TMD), and is one of the most common regional pain syndromes (Macfarlane et al.,
2002). These conditions are primarily present in young and middle-aged adults and are
less common among children or the elderly. There is also a large gender difference, with
women twice as likely to report a TMD problem (LeResche, 1997). Orofacial pain may
arise after a temporomandibular joint suffers injury and mechanical function is impaired.
Poor functional habits such as grinding the teeth or habitual tensing of the jaw
musculature may also initiate a TMD or exacerbate an already existing TMD. A recent
epidemiological study found 5.3% of the US population to be experiencing some form of
TMD pain (Lipton, Ship, & Larach-Robinson, 1993). Other prevalence studies have
placed the incidence of TMD even higher, at about 12% (Von Korff, Dworkin, LeResche,
& Kruger, 1988). As with most chronic problems, these conditions are associated with
high health care costs and lost productivity (White, Williams, & Leben, 2001).
Contributing to these high costs and loss of productivity is likely the high incidence of
comorbid physiological conditions present in orofacial pain patients (e.g., interstitial
cystitis, fibromyalgia, GERD) and suggests broad physiological dysfunction (Aaron,
Burke, & Buchwald, 2000). Clearly, an orofacial pain condition can be a complex
problem with potentially wide-ranging physiological effects.
Compared to pain-free controls, chronic orofacial pain patients have reported
lower pain tolerance and thresholds (Maixner, Fillingim, Booker, & Sigurdsson, 1995),
more emotional and cardiovascular reactivity (Curran, Carlson, & Okeson, 1996), more
psychological distress, more fatigue, and more sleep dysfunction (Carlson et al., 1998).
Several studies have also demonstrated the comorbidity and increased incidence of
anxiety (Kight, Gatchel, Ellis, & Holt, 1999; McNeil et al., 2001) and depression (Banks
& Kerns, 1996) in orofacial pain patients. These characteristics may reflect a more
fragile and reactive behavioral response system. In fact, orofacial pain patients have
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demonstrated heightened emotional reactivity to stressors. For example, Curran and
colleagues found that patients with masticatory muscle pain responded to a standard math
stressor (serial subtraction) with more anger when compared to controls (Curran et al.,
1996). In a similar study, however, Carlson and colleagues found significant emotional
and physiological responses in both an orofacial pain sample and matched controls to a
standard math stressor (serial subtraction) (Carlson et al., 1998). The lack of significant
differences in emotional responding between patients and controls after exposure to a
standard stressor may reflect study design or measurement issues. It has been suggested
that the use of a personally-relevant stressor is critical in differentiating TMD patients
from controls on physiological domains (Flor, Birbaumer, Schugen, & Lutzenberger,
1992; Flor, Birbaumer, Schulte, & Roos, 1991; Ohrbach, Blascovich, Gale, McCall, &
Dworkin, 1998).
Another feature of these patients is comorbidity to traumatic events. A recent
study found 49.8% of over twelve hundred orofacial pain patients reported traumatic life
events (de Leeuw, Bertoli, Schmidt, & Carlson, 2005b). The incidence of orofacial pain
patients reporting clinically significant symptomatology of PTSD is also high, ranging
from 15% to 23% (de Leeuw, Bertoli, Schmidt, & Carlson, 2005a; Sherman, 1998;
Sherman, Carlson, Wilson, Okeson, & McCubbin, 2005). A diagnosis of PTSD is
associated with persistent hyperarousal as well as increased physiological reactivity when
exposed to a reminder of the traumatic event (DSM-IV). These factors likely contribute
to a reduction in the range of behavioral regulation and an increase in emotional
reactivity.
The systemic and chronic level of activation present in orofacial pain patients,
that are even more pronounced in patients reporting a traumatic stressor, does not seem to
easily abate or subside over time. The characteristics commonly found in chronic
orofacial pain patients of increased emotional reactivity, increased incidence of
psychopathology, and increased physiological reactivity imply a compromised autonomic
regulation system and suggests the need for a quantitative measure of autonomic system
regulation and response. A physiological measure representative of autonomic balance
would provide a better understanding of the associations among emotional and

2

physiological response to environmental challenge by providing an index of autonomic
homeostasis and flexibility. Heart rate variability is a physiological index that has
demonstrated usefulness in providing a quantitative measure of sympathetic and
parasympathetic activity, and is a good candidate to index autonomic balance.

Heart Rate Variability
Heart rate variability (HRV) is an index of fluctuations in the time interval
between normal heartbeats. Fluctuations in inter-beat interval are expressed as beat-tobeat alterations in heart rate and are a representation of the heart’s ability to respond to
normal regulatory impulses that affect heart rhythm (Akselrod, 1995). This index is
commonly presented as a function of power at different frequency ranges of heart
functioning. The lower frequency range (LF) includes both sympathetic and
parasympathetic influences (Chiu & Kao, 2001). Basic studies using atropine and similar
drugs that block or dampen vagal stimulation to the heart have resulted in strongly
reduced LF power (Akselrod et al., 1985; Akselrod, Gordon, & Ubel, 1981). The higher
frequency range (HF) reflects vagal activity and is thus parasympathetically modulated
(Akselrod et al., 1981). Increased HF power has been associated with higher
parasympathetic activity in studies of paced breathing (Ring et al., 1999) and treatment
for depression (Carney, Freedland, & Stein, 2000). Total vagal blockade essentially
eliminates the power in the HF range, and reduces power in the LF range. With gradual
blockade of vagal input, the ratio of LF to HF power increases, demonstrating a shift in
the sympathovagal equilibrium towards sympathetic dominance (Malliani, Pagani,
Lombardi, & Cerutti, 1991).
Basic research into demographic and physiological correlates of HRV has shown
an association with age (Carter, Banister, & Plaber, 2003; Fagard, Pardaens, & Staessen,
1999), regular exercise and aerobic fitness (Carter et al., 2003), and genetic factors
(Singh, Larson, O'Donnell, & Levy, 2001). Functionally, respiration pattern is a major
component in the study of HRV. Respiratory Sinus Arrhythmia (RSA) refers to the
cyclical fluctuations in heart rate that coincide with respiratory cycle. Heart rate
increases during inspiration and decreases during exhalation. In HRV frequency indices,
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RSA is reflected in the HF range and has been used as a non-invasive measure of
parasympathetic function (Task Force, 1996).

Heart Rate Variability and Trauma
The ability of HRV to provide a quantitative index of autonomic functioning is
most apparent in studies of trauma survivors suffering from posttraumatic stress disorder
(PTSD). A diagnosis of PTSD may result in reduced HRV, reduced emotional inhibition,
and a lack of behavioral flexibility in stressful situations. To test these hypotheses,
Cohen and colleagues conducted two studies (1998, 2000) comparing PTSD patients with
age and sex matched controls on HRV indices while resting, when discussing a
personally relevant stressor, and post-stressor. The pattern of autonomic response in the
PTSD participants showed no significant change across study periods, while the control
group showed a decrease in HF and an increase in LF during the stressor period
compared to the baseline and post periods (Cohen et al., 2000; Cohen et al., 1998). The
response to recalling a distressing event by the control group appears to represent a
normal and well-balanced autonomic reaction. In contrast, the response of the PTSD
patients demonstrates a lack of heart rate variability in either a restful or distressing state.
This rigidity of autonomic activity may reflect the constant state of hyperactivation
characterized by increased sympathetic activity and decreased parasympathetic activity in
PTSD sufferers. These physiological characteristics of the PTSD patients in these studies
suggest chronic dis-inhibition of sympathetic activity.
Engaging in inhibitory control of sympathetic activity after a stressor likely
represents a healthy, balanced psychophysiological response system, while dis-inhibition
of sympathetic activity suggests psychophysiological inflexibility. Thayer has
developed a model of neurovisceral integration (Thayer & Lane, 2000), which seeks to
demonstrate how anxiety related arousal represents a disinhibition of positive feedback
circuits normally under tonic inhibitory control. This model strives to account for the
interactions of cognitive, affective, behavioral, and physiological states and dispositions
across the spectrum of normal and pathological functioning. A reduction in overall
system flexibility is thought to result from a disinhibition of sympathetic nervous system
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activity. When vagal input to the heart is decreased, the individual is less able to track
rapid changes in environmental demands due to the slow response of sympathetic input.
Instead of the negative feedback loop associated with increased parasympathetic
functioning and subsequent inhibition of sympathetic activation after arousal, a positive
feedback loop becomes dominant in situations where there is sustained attention or
vigilance to environmental stimuli (Porges, 1992; Thayer & Lane, 2000). Thayer
proposes that autonomically mediated HRV provides an index of neurovisceral
integration and system flexibility by providing quantitative values of sympathetic and
parasympathetic activity present at the sino-atrial node of the heart.
The use of heart rate variability to investigate autonomic activity in orofacial pain
patients might broaden the understanding of the dynamic relationships among emotional
reactivity, negative life experiences, and the development of a chronic pain condition.
Further, the information provided by a focused and controlled analyses of HRV with
orofacial pain patients may provide a distinct quantitative index of autonomic regulation
and demonstrate a consistent pattern of behavioral disinhibition in these patients.

Study Aims and Hypotheses
The present study has two general aims. First, this study investigated differences
in heart rate variability indices between chronic orofacial pain patients and pain-free
controls at rest, during a stressor condition, and during a post-stressor recovery period.
The stressor condition consisted of having the participant discuss a personally relevant
distressing experience. Second, this study investigated factors including psychological
distress (e.g., anxiety, depression), social-environment (e.g., social support, social
constraints), disposition (e.g., emotion regulation), and family of origin characteristics
that may be associated with HRV indices during the baseline, stressor, and recovery
periods in the orofacial pain sample as compared to a pain-free matched control sample.
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Specific Hypotheses
1) While quietly sitting during baseline assessment, orofacial pain patients will
have lower HF, higher LF, and higher LF/HF ratio HRV indices compared to pain-free
controls (Porges, 1992; Thayer & Lane, 2000).
2) During the recovery period, orofacial pain patients will have lower HF, higher
LF, and higher LF/HF ratio HRV indices compared to pain-free controls (Porges, 1992;
Thayer & Lane, 2000).
3) Orofacial pain patients reporting a traumatic stressor will show very little
change in HRV indices between baseline, stressor, and recovery (Cohen et al., 2000;
Cohen et al., 1998).
4) Orofacial pain patients will report more emotional reactivity to the stressor
condition as reported on the EAS compared to pain-free controls (Curran et al., 1996;
Maixner et al., 1995).
5) Orofacial pain patients will report more psychological distress, sleep
dysfunction, and fatigue than pain-free controls on self-report measures (Carlson et al.,
1998; Kight et al., 2001).
6) Orofacial pain patients will report less social support, more social constraints,
and a family-of-origin environment characterized by conflict and aggression, compared
to pain-free controls (Repetti, Taylor, & Seeman, 2002).
7) Orofacial pain patients will report use of the emotion regulation strategy of
suppression and less use of reappraisal compared to pain-free controls (Gross & John,
2003).

Copyright © John E Schmidt 2006
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Chapter 2
Methods
Setting and Participants
This study was approved by the University of Kentucky Institutional Review
Board and all participants provided written informed consent. Study participants were
recruited from patients seeking care at the University of Kentucky Orofacial Pain Center.
Controls were recruited by posting flyers describing the study throughout the University
of Kentucky Medical Center. Controls were matched to patients on age, height, and
weight. All participants were recruited and completed the study between February and
August, 2005.
Study inclusion criteria for patients were as follows: (1) age 18 years or older; (2)
female; (3) Research Diagnostic Criteria/Temporomandibular Disorders (RDC/TMD)
Axis I TMD diagnosis (Dworkin and LeResche, 1992) made by a faculty member or
resident trained in orofacial pain examination and management; (3) diagnosis of pain
duration of at least two months; (4) current pain level of at least 3 on a 0-10 visual analog
scale (0=no pain and 10= worst pain imaginable); (5) no past or current history of
hypertension or heart disease; (6) not taking any cardiovascular control medication (e.g.,
beta-blockers); (7) no history of asthma or other chronic respiratory conditions; (8) no
history of diabetes; (9) not pregnant at time of study participation; (10) prior to
participation, resting blood pressure must meet the following criteria: systolic blood
pressure < 140mmHg, diastolic blood pressure < 90mmHg (Chobanian et al., 2003).
Controls met the same criteria with the exception of items 2, 3, and 4. In addition,
controls had no current or past chronic pain condition (e.g., back pain, TMD, arthritis).
All participants were compensated $40 for completion of this study.
The participants in this study were 22 female orofacial pain patients with a mean
age of 41.0 years (sd=12.6), a mean weight of 151.5 pounds (sd=29.3), and a mean height
of 64.5 inches (sd=1.8). Patients were matched to 23 pain-free controls with a mean age
of 36.0 years (sd=11.7), a mean weight of 149.2 pounds (sd=24.1), and a mean height of
64.8 inches (sd=2.4).
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Design
The study design compared patients with orofacial pain to matched pain-free
controls on a standard set of psychometric measures and on physiological responses
before, during, and after a laboratory challenge. Dentists experienced in the diagnosis
and treatment of TM disorders recruited patients during the initial diagnostic
appointment. Patients were then recruited by the principal investigator (PI) and
scheduled for participation. Control participants were matched to patients on height,
weight, and age prior to study participation. The laboratory challenge for all participants
was administered by the PI.

Dependent Measures
Prior to the initial evaluation by the attending dentist, all patients completed an
orofacial pain questionnaire that gathers demographic data, historical information
regarding pain, a general medical history, and a battery of psychological questionnaires.
The orofacial pain examination includes a detailed history of the patient’s chief
complaints(s), associated symptoms, TMJ noise, mandibular dysfunction, parafunctional
habits, past trauma, previous treatments/consultations for their chief complaint(s), as well
as psychosocial history. The battery of psychological questionnaires administered to
patients included the following measures:
Symptom Check List –90 (SCL-90). The SCL-90-R (Derogatis, 1979) is a 90-item
multi-dimensional self-report measure of psychological functioning scored on a fivepoint scale of distress (0-4). The specific dimensions on the SCL-90-R include
somatization, obsessive-compulsive behavior, interpersonal sensitivity, depression,
anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. A global severity
index is also available from this measure. Test-retest reliabilities range from r=0.78 to
0.90 for non-patient samples, and internal consistencies range from 0.77 to 0.90
(Derogatis, 1979).
Pittsburgh Sleep Quality Index (PSQI). The PSQI (Buysse, Reynolds, Monk,
Berman, & Kupfer, 1989) is a 12-item measure of sleep quality. The PSQI gathers
information regarding the amount of hours the patient sleeps each night, the amount of
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hours in bed each night, how often the patient is woken up and why, as well as how
difficult it is for the patient to return to sleep upon awakening. The PSQI has exhibited
test-retest stability (full scale r = 0.85), good overall internal consistency (α = 0.83), and
provides a valid and reliable assessment of overall sleep quality and disturbance. (Buysse
et al., 1989; Carpenter & Andrykowski, 1998).
Posttraumatic stress disorder Check List – Civilian version (PCL-C). The PCL-C
(Weathers, Litz, Herman, Huska, & Keane, 1993) is a self-report measure used to assess
the incidence of significant life stressors and prevalence of PTSD symptomatology. The
patient first identifies significant stressors they may have experienced from a list (e.g.,
military combat, violent attack, incarceration, natural or man-made disaster, severe auto
accident, sudden injury/serious accident, observed someone hurt or killed). The patient
selects the most significant stressor and the notes the date of occurrence. The patient then
answers 17 symptom-related items by noting how much he or she has been bothered by
each symptom in the last month. The items are scored on a five-point Likert scale from 1
(not at all) to 5 (extremely). The PCL-C provides a total score as well as three subscale
scores (reexperiencing, avoidance/numbing, and arousal). The PCL-C has exhibited testretest stability (r = 0.96), good overall internal consistency (alpha = 0.92), and provides a
valid and reliable assessment of the presence of PTSD symptoms (Blanchard et al.,
1996). The PCL-C has demonstrated efficacy in the screening of PTSD in orofacial pain
patients (Sherman, 1998; Sherman et al., 2005).
Multi-dimensional Fatigue Symptom Inventory (MFSI). The MFSI (Stein, Martin,
Hann, & Jacobsen, 1998) is a 30-item measure designed to identify 5 facets of fatigue: 1)
global experience of fatigue; 2) somatic symptoms of fatigue; 3) cognitive symptoms of
fatigue; 4) affective symptoms of fatigue; and 5) behavioral symptoms of fatigue.
Patients are asked to rate each statement according to how true it has been over the past 7
days along a 5-point Likert scale from 0 (not at all) to 4 (Extremely). The MFSI has
demonstrated efficacy in predicting the presence and magnitude of self-reported fatigue
in orofacial pain patients (de Leeuw, Studts, & Carlson, 2005).
Emotion Regulation Questionnaire (ERQ). The ERQ (Gross & John, 2003) is a
10-item measure designed to assess individual differences in the habitual use of two

9

emotion regulation strategies: cognitive reappraisal and expressive suppression.
Respondents are asked to indicate strength of agreement with each item on a seven-point
Likert scale from 1 (strongly disagree) to 7 (strongly agree). The ERQ has shown good
overall internal consistency (coefficient alphas: reappraisal = 0.79, suppression = 0.73)
(Gross & John, 2003).
Emotion Assessment Scale (EAS). The EAS (Carlson et al., 1989) is a 24-item
scale designed to measure eight fundamental dimensions of emotional responses
(surprise, fear, disgust, anger, guilt, anxiety, sadness, and happiness). The EAS contains
24 visual analog scale items that range from 0 to 100 mm. The EAS has a split-half
reliability of .94 (Carlson et al., 1989).
Family of Origin Scale (FOS). The FOS (Hovestadt, Anderson, Piercy, Cochran,
& Fine, 1985) is a 40-item measure of the perceived tone of social-emotional
relationships in the family-of-origin, focusing on warmth and acceptance. The
participant is asked to indicate strength of agreement with each item on a five-point
Likert scale from 1 (strongly disagree) to 5 (strongly agree). The 15-item short form was
used in this study (Ryan, Powel, Kawash, & Fine, 1995). The FOS has shown good
overall internal consistency (coefficient alphas: total 40-item form=0.96, 15-item short
form=0.95).
Social Constraints Scale (SCS). The SCS (Lepore & Ituarte, 1999) is a 15-item
self-report measure of the extent to which the participant’s social environment inhibits
expression of distressing thoughts and feelings. This study used the “friends/family”
version of the SCS. The participant notes incidence of different social experiences in the
past month using a 4-point Likert scale. The scale ranges from “never” to “often.” The
test-retest reliability of the SCS is 0.71 at nine months, and coefficient alpha has ranged
from 0.89 to 0.92 (Lepore & Ituarte, 1999).
Duke-UNC Functional Social Support Questionnaire (DUKE-SSQ). The DUKESSQ (Broadhead, Gehlbach, De Gruy, & Kaplan, 1988) is an eight-item,
multidimensional, functional social support questionnaire designed for use with medical
populations. The participant notes level of satisfaction with amount of social support in
various areas using a 5-point Likert scale. The scale ranges from “much less than I
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would like” to “as much as I would like.” The DUKE-SSQ yields a total score, and
coefficient alpha has ranged from 0.86 to 0.88 (Andrykowski, Cordova, Studts, & Miller,
1998; Schmidt & Andrykowski, 2004).
Control participants were administered the following questionnaires: Symptom
Check List –90 (SCL-90), Pittsburgh Sleep Quality Index (PSQI), Posttraumatic stress
disorder Check List – Civilian version (PCL-C), Multi-dimensional Fatigue Symptom
Inventory (MFSI), Emotion regulation questionnaire (ERQ), Emotion Assessment Scale
(EAS), Family of Origin Scale (FOS), Social Constraints Scale (SCS), and the DUKESocial Support Questionnaire (DUKE-SSQ).

Current stage of menstrual cycle
Day of menstrual cycle was recorded for participants by asking for the last day of
their previous period. The menstrual cycle is divided into four phases: menstruation
(days 1-5), proliferative phase (days 6-13), ovulation (day 14), and luteal or secretory
phase (days 15 to 28). Research has demonstrated that autonomic regulation of the heart
fluctuates during the menstrual cycle with HRV being lower in the luteal phase that in the
other phases (Landen et al., 2004; Sato, Miyake, Akatsu, & Kumashiro, 1995). The
results of these studies suggest that sympathetic nervous system activity is dominant
during the luteal phase. This difference is thought to be due to high concentrations of
progesterone present during this phase of the menstrual cycle.

Physiological measures
The physiological measures were recorded using the MP150 Biopac data
acquisition system (Biopac Systems, Inc.). The configuration for this study included the
electrocardiogram and end-tidal carbon dioxide amplifier modules. Cardiovascular
activity was recorded using three Ag/AgCl electrodes using shielded leads connected to
an ECG100C electrocardiogram amplifier module. The sampling rate for this module
was set to 1000 samples/second. The electrodes were placed in the Lead I configuration,
with the positive and negative electrodes connected to the inside of the forearms (Guyton,
1991). Module settings were as follows: gain = 1000; high pass filter = .05Hz; notch
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interference filter (35Hz) = on.
To calculate the heart rate variability frequency domain indices, the ECG signal
was first filtered and transformed into R-R intervals using the Biopac Aquire system
software. These data were then saved as a text file for frequency domain analyses.
Frequency domain analyses were completed using HRV Analysis Software version 1.1
SP1 by Biomedical Signal Analysis Group, Department of Applied Physics, University of
Kuoplo, Finland. This software package is a stand-alone HRV analysis program that
provides a variety of HRV indices including non-parametric Fast Fourier Transform
(FFT) spectrum values of HRV, geometric HRV measures, and parametric Auto
Regressive spectrum values of HRV. For this study, the non-parametric FFT HRV
values in normalized units will be reported. These include the Low Frequency (LF)
index, the High Frequency (HF) index, and the LF/HF ratio.
End Tidal Carbon Dioxide and breathing rate were recorded by placing a nasal
canula under the participant’s nose. The canule tubing was connected a CO2100C
amplifier module. This module records quickly varying carbon dioxide concentration
levels, and provides a continuous measure of ETCO2 throughout the study. Sampling
rate for this module is 100ml/min. The mean peak ETCO2 value was recorded as a
percentage. Breathing rate in breaths per minute was also recorded via the data collected
with this module. The only adjustable setting for this module is gain, which was set to
5%CO2/volt for the present study. Due to equipment problems, ETCO2 data were not
available for all participants therefore these data will not be reported. Breathing rate was
successfully recorded for all study participants.

Procedure
Prior to the laboratory evaluation, participants completed an informed consent and
were interviewed to ensure they met all screening criteria. Height and weight were
recorded and the participant then completed study psychometric measures in a quiet room
free from distractions. Once the study measures were completed, the PI introduced the
participant to the physiological laboratory and equipment. The participant was seated in
a comfortable chair and the physiological recording leads were attached. After the leads
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were attached and tested, the participant rested quietly for a five-minute adaptation
period. Following this, a ten-minute baseline recording was completed (baseline period).
During the baseline, the participant was instructed to sit quietly and was alone in the
laboratory. The first EAS was administered after the baseline recording. This was
followed by the laboratory challenge (recall period).
The laboratory challenge consisted of having the participant describe one past
significant stressful negative life event for ten-minutes. Participants were encouraged not
to ‘relive’ negative life experiences, only to describe them. Prior to beginning the
laboratory challenge, the PCL-C was reviewed and if a traumatic event was reported, the
participant was asked to describe the event marked as most distressing. If no traumatic
event was reported on the PCL-C, the participant was asked to describe the most
significant stressful life event experienced. All narratives were videotaped. The
videotapes from this study will be analyzed and coded for a future paper. Prior to
describing the significant life event, a two-minute narrative trial was completed to
acclimate the participant to the stimulus condition. The participant was instructed to
describe the day’s activities while facing the video camera. During the two-minute
acclimation and the ten-minute narrative, the participant was alone in the laboratory.
This stimulus procedure has been used to investigate HRV differences among
normal controls and with individuals diagnosed with PTSD and panic anxiety (Cohen et
al., 2000; Cohen et al., 1998). This type of procedure has also been successfully used in
research concerning emotional expression with normals (Campbell, 2001), cancer
patients (Graves et al., 2005), and with TMD patients (Ohrbach et al., 1998).
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The instructions for the emotion stimulus protocol were as follows:
Two-minute acclimation: I’d like to help you get more comfortable with talking
out loud while facing the video camera. During the next two minutes I would like
you to face the camera and talk about your activities for the day. Talk about what
you’ve already done today and what you plan on doing during the rest of the day.
The important thing is that you describe your activities in as much detail as
possible. Remember to talk directly into the camera, being careful not to slouch
down in the chair or look down at the floor. If you find you’ve run out of things
to say, its okay to repeat some of the things you might have said earlier. The
important thing is just that you try to keep talking during the whole two minutes.
I’ll leave the room now, and then let you know when the two-minutes are up.
Ten-minute narrative: During the next 10 minutes, I want you to talk about the
most traumatic and upsetting experience of your life. When talking, try not to
relive the event. Instead, describe the event and your thoughts and feelings about
the event. Remember to talk directly into the camera, without slouching or
looking down at the floor, and to talk about your thoughts and feelings about this
traumatic and upsetting experience in your life. If you find you’ve run out of
things to say, its okay to repeat some of the things that you might have said
earlier. The most important thing is that you continue talking as much as possible
about your thoughts and feelings about this traumatic and upsetting experience.
You will be alone in this private room to talk about the experience, with no one
listening to you. I will knock on the door and then enter to let you know when the
ten-minutes are up.
The laboratory challenge was followed by a ten-minute post-stressor recording
(recovery period). Again, the participant was alone in the room during the recording.
This was followed by completion of another EAS. Participants were then debriefed and
excused from the study.

Copyright © John E Schmidt 2006
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Chapter 3
Results
Analytic Strategy
Overall 2 (pain patients vs. matched pain-free controls) X 3 (baseline, stressor,
and recovery) repeated measures MANOVAS were performed on the physiological and
emotional status data. Specific hypotheses for physiological and emotional status
variables were tested with focused contrasts. Hypothesized differences between the two
groups on general psychological and social-environment variables were compared with
univariate ANOVAs. All statistical analyses were completed with the Statistical Package
for the Social Sciences, Release 11.5.0.0 (SPSS Inc., 1989-2004). The criterion for
statistical significance was set at p < .05. To control for Type 1 error associated with
multiple comparisons, Bonferroni corrections were used as appropriate. Effect sizes for
hypothesized analyses are reported using Cohen’s d. Correlations among the main study
variables for each group are presented in Tables 3.1 and 3.2.

Pain Assessment
Pain evaluations were completed prior to beginning the laboratory challenge to
ensure the patients diagnosed with Masticatory Muscle Pain (MMP) were indeed
experiencing ongoing muscle pain at the time of the study. The MMP group reported a
mean present pain intensity over the previous week of 53.50 (sd = 25.81) on the pain
VAS (‘0’ to ‘100’ mm) where ‘0’ is ‘no pain at all’ and ‘100’ is ‘the worst pain
imaginable.’ The Pain Free Control (PFC) group reported no chronic pain condition or
present pain complaint at the time of study participation.

Current stage of menstrual cycle
Prior to the completing the physiological analyses, the two groups were compared
on phase of menstrual cycle during time of study participation. This comparison was
done to ensure there was an equal distribution of participants in the luteal phase between
the groups at the time of study completion. A Chi-square comparison was completed and
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showed no significant difference in the number of participants in the luteal phase, MMP
= 6 vs. PFC = 3; chi-square (1,44) = 1.42, p < .30.

Incidence and Severity of Traumatic Stressors
The two groups were compared on number of participants that reported a
traumatic stressor and met criteria for clinically significant PTSD symptomatology
according to the cut-off score established by Blanchard et al. (1996). A Chi-Square
comparison between the two groups was completed and showed no significant difference
in the number of participants reporting a significant stressor on the PCL-C, MMP = 14
vs. PFC = 11; chi-square (1,44) = 1.13, p < .30. These two sub-groups were compared on
the PCL-sum score to determine if there was a significant difference in reported PTSD
symptom intensity. Results showed no significant difference between the two sub-groups
on PCL-sum score, MMP = 35.14 vs. PFC = 31.18; F(1,24) = .79, p < .40. The number of
participants that met the cut-off score for clinically significant PTSD symptomatology
was n = 5 (23%) for the MMP group and n = 1 (4%) for the PFC group.

Physiological Variables
The overall MANOVA for HRV indices indicated no significant main effect for
group differences between the MMP group and PFC group, Wilks’ Lambda (3,41) = .86,
p < .10. Results showed a significant main effect for time, Wilks’ Lambda (6,38) = .38, p
< .001. Pairwise comparisons among the HRV indices across the three study time
periods showed significant differences between the baseline and recall periods (LF
baseline = 55.45, recall = 74.23, p < .001; HF baseline = 44.55, recall = 25.34, p < .001;
Ratio baseline = 1.55, recall = 4.06, p < .001) and the recall and recovery periods (LF
recall = 74.23, recovery = 59.07, p < .001; HF recall = 25.34, recovery = 41.55, p < .001;
Ratio recall = 4.06, recovery = 1.96, p < .001). These data confirm the effectiveness of
the stress recall procedure used in this study. There was no main effect for the interaction
of time x group, Wilks’ Lambda (6,38) = .87, p < .10.
The overall MANOVA was followed by focused contrasts to evaluate the a priori
hypothesis that the MMP group would have lower HF, higher LF, and higher LF/HF ratio
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HRV indices at baseline compared to the PFC group. Focused contrasts showed
marginally significant differences in the LF and HF baseline HRV values with the MMP
group higher on LF HRV, MMP = 60.11 vs. PFC = 51.18, F(1,44) = 3.86, p < .06,
Cohen’s d = .59, and lower on HF HRV, MMP = 39.89 vs. PFC = 48.82, F(1,44) = 3.86,
p < .06, Cohen’s d = .59, when compared to the PFC group. As expected the LF/HF
baseline value was significantly higher in the MMP group, MMP = 1.97 vs. PFC = 1.16,
F(1,44) = 9.17, p < .01, Cohen’s d = .90, when compared to the PFC group.
To evaluate the a priori hypothesis that the MMP group will have higher LF,
lower HF, and higher LF/HF ratio HRV indices at recovery compared to the PFC group,
univariate comparisons between the experimental groups were completed on these HRV
indices. Results showed the MMP group to be significantly higher on LF compared to
the PFC group, MMP = 63.87 vs. PFC = 54.96, F(1,44) = 4.30, p < .05, Cohen’s d = .62,
significantly lower on HF compared to the PFC group, MMP = 36.13 vs. PFC = 46.49,
F(1,44) = 6.11, p < .056, Cohen’s d = .74, and significantly higher on the LF/HF ratio
compared to the PFC group, MMP = 2.72 vs. PFC = 1.26, F(1,44) = 6.47, p < .05,
Cohen’s d = .75. Characteristics of the HRV indices are presented in Table 3.3. Figures
3.1, 3.2, and 3.3 provide graphical displays of the LF, HF, and LF/HF ratio HRV indices
group differences across study periods.
To determine if the differences were due to initial baseline differences between
the groups, Analyses of Covariance (ANCOVA) using the initial baseline values as the
covariate were completed for the recall and recovery period HRV indices. No differences
were found between the two groups on recall or recovery period HRV indices when
baseline values were used as covariates. These results of the ANCOVA analyses are
presented in Table 3.4.
A 1 (stressor) X 3 (baseline, stressor, recovery) repeated measures analyses of
variance was used to evaluate the hypothesis that participants in the MMP group
reporting a traumatic stressor will show very little change in HRV indices between the
three recording periods. Of the 22 MMP participants in this study, 14 (64%) reported a
traumatic stressor. The overall MANOVA for the HRV indices indicated no significant
main effect for time, Wilks’ Lambda (2,12) = .52, p < .20. Repeated measures univariate
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analyses were significant for LF HRV [F(2,12) = 6.40, p < .05, HF HRV, F(2,12) = 6.40,
p < .01, and LF/HF ratio, F(2,12) = 7.26, p < .01 across the three study periods. Withinsubject focused contrasts showed a significant difference between the baseline and recall
periods for all HRV indices, however, there were no significant differences between the
recall and recovery periods on the HRV indices. The HRV means and standard
deviations for the MMP patients that reported a traumatic stressor are shown presented in
Table 3.5.
Breathing rates in breaths-per-minute were also recorded and calculated for each
period. Univariate comparisons between groups for the baseline, MMP = 18.8 vs. PFC =
16.4, F(1,44) = 2.57, p < .200, and recovery periods, MMP = 18.2 vs. PFC = 15.6,
F(1,44) = 3.33, p < .10, showed no significant difference in breathing rates between the
two experimental groups.

Emotional Reactivity
Emotional status was assessed immediately following the baseline period and
again, after the recovery period. All study participants completed the EAS at these timepoints. The overall 2 (group) X 2 (baseline vs. recovery) MANOVA on the emotional
reactivity variables indicated a significant difference between the MMP and PFC groups,
Wilks’ Lambda (16,27) = .245, p<001. To evaluate the hypothesis that the MMP group
would report more emotional reactivity to the stressor period compared to the PFC group,
univariate comparisons were completed on the emotional status variables. The MMP
group reported more ‘anxiety’ prior to the stressor, MMP = 25.0 vs. PFC = 11.0, F(1,43)
= 4.35, p < .05, Cohen’s d = .62, and more ‘anger’ after the recovery period, MMP =
11.18 vs. PFC = 2.74, F(1,43) = 5.87, p < .05, Cohen’s d = .72, compared to the PFC
group. In contrast, the PFC group reported more ‘happiness’ prior to the stressor, MMP
= 25.6 vs. PFC = 42.8, F(1,43) = 4.09, p < .05, Cohen’s d = .60, than did the MMP group.

Psychological, physical, and social Variables
The between groups MANOVA on the psychological, fatigue, and sleep variables
indicated a significant difference between the MMP group and PFC group, Wilks’
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Lambda (15,29) = .152, p < 001. To evaluate the hypothesis that the MMP group would
report more psychological distress compared to the PFC group, a univariate comparison
was completed on the Global Severity Index (GSI) of the SCL-90-R. The MMP group
scored significantly higher on the GSI, F(1,44) = 16.69, p < .001, Cohen’s d = 1.22,
compared to the PFC group. This analysis was followed by post-hoc comparisons on the
individual SCL-90-R subscales using Bonferroni corrections to control for Type 1 error.
The MMP group reported greater somatization, F(1,44) = 44.71, p < .001, Cohen’s d =
2.0, obsessive-compulsive behavior, F(1,44) = 7.74, p < .01, Cohen’s d = .81, depression,
F(1,44) = 10.03, p < .01, Cohen’s d = .95, and anxiety, F(1,44) = 7.54, p < .01, Cohen’s d
= .82 on the SCL-90-R subscales as compared to the PFC group. To evaluate the
hypothesis that the MMP group would report more fatigue compared to the PFC group,
univariate comparisons were made on the subscales of the MFSI. The MMP group
reported significantly more general fatigue, F(1,44) = 13.56, p < .001, Cohen’s d = 1.22,
physical fatigue, F(1,44) = 32.99, p < .001, Cohen’s d = 1.74, and mental fatigue,
F(1,44) = 12.87, p < .001, Cohen’s d = 1.01, than the PFC group. The MMP group also
reported significantly less vigor F(1,44) = 11.72, p < .001, Cohen’s d = 1.02, compared to
the PFC group. As hypothesized, the MMP group reported more sleep dysfunction
compared to the PFC group, F(1,44) = 56.88, p < .001, Cohen’s d = 2.0. These data are
presented in Table 3.6.
To evaluate the hypothesis that the MMP group would report more social
constraints, less social support, and a family-of-origin environment characterized by
conflict and aggression when compared to the PFC group, univariate comparisons were
completed on these variables. A significant difference was found on perceived social
constraints, SCS: F(1,44) = 7.40, p < .01, Cohen’s d = .78, with the MMP group reporting
a more constraining social environment than did the PFC group. In contrast, no
difference was noted between the two groups on perceived social support, DUKE-SSQ:
F(1,44) = .08, p < .80. The MMP group also reported a more dysfunctional family-oforigin, FOS: F(1,44) = 4.46, p < .05, Cohen’s d = .65, compared to the PFC group.
These results are presented in Table 3.7.
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To test the hypotheses that the MMP group would report more use of the emotion
regulation strategy of reappraisal and less use of suppression compared to the PFC group,
univariate comparisons were completed on these two variables. The two groups were not
significantly different on the measured emotion regulation strategies of reappraisal, ERQReappraisal: F(1,44) = .93, p < .40, or suppression, ERQ-Suppression: F(1,44) = .04, p
< .900. These data are presented in Table 3.7 as well.
A post-hoc comparison on social environment measures was then completed
among the participants in the MMP group who reported a traumatic stressor. Results
showed that the MMP group participants reporting clinically significant PTSD
symptomatology reported significantly higher perceived social constraints, MMP(PTSDpositive) = 43.0 vs. MMP(PTSD-negative) = 29.6; F(1,13) = 6.33, p < .05, Cohen’s d =
1.5, and lower perceived social support, MMP (PTSD-positive) = 23.2 vs. MMP (PTSDnegative) = 33.1; F(1,13) = 8.78, p < .05, Cohen’s d = 1.8, compared to the MMP group
participants who reported a traumatic stressor, but did not meet the cut-off for clinically
significant PTSD symptomatology. There were no differences on the Family of Origin
measure between these two sub-groups of patients, MMP (PTSD-positive) = 41.7 vs.
MMP (PTSD-negative) = 38.0; F(1,13) = .25, p < .700.

Copyright © John E Schmidt 2006
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Measure
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1. LF/HF-B
2. LF/HF-R
3. VAS
4. Duration
5. PSQI
6. SCS
7. DUKE
8. ERQ-R
9. ERQ-S
10. FOS
11. GSI
MFSI
12. General
13. Emotion
14. Physical
15. Mental
16. Vigor

1

2

3

4

5

6

7

8

9

10

11

1.0
.555*
-.351
.219
.178
-.538*
.736*
-.227
-.057
.371
-.285

1.0
-.294
.191
.372
-.223
.329
-.226
-.252
.208
.010

1.0
.311
.264
.710**
-.624*
-.198
.617
-.777**
.447

1.0
-.167
.335
-.031
-.011
.209
-.165
.082

1.0
-.188
-.110
-.176
-.016
.153
.432

1.0
-.717*
.306
.340
-.604*
.486

1.0
-.219
-.258
.496
-.495

1.0
-.022
-.266
-.068

1.0
-.318
.213

1.0
-.221

1.0

-.437
-.230
-.354
-.122
.041

-.192
.050
-.101
.082
-.123

.550
.647
.622
.359
-.290

.095
.121
.347
.156
-.385

.439
.541*
.419
.472
-.460

.373
.500
.591*
.368
-.208

-.499
-.454
-.682*
-.358
.178

-.275
-.102
.039
.162
.261

.163
.334
.298
.206
-.203

-.404
-.251
-.346
-.096
.073

.505
.850*
.820*
.827*
-.326

12

13

14

15

1.0
.600*
.565*
.337
-.615*

1.0
.775*
.637*
-.584*

1.0
.585*
-.423

1.0
-.161

* correlation is significant at the .01 level.
Note. LF/HF=Low Frequency to High Frequency HRV Ratio (B=Baseline, R=Recovery). VAS=Visual Analog Scale of
present pain. Duration=Duration of pain. PSQI=Pittsburgh Sleep Quality Index. SCS=Social Constraints Scale. DUKE-SSQ:
Duke Social Support Questionnaire. ERQ-R=Emotion Regulation Questionnaire-Reappraisal. ERQ-S=Emotion Regulation
Questionnaire-Suppression. FOS=Family of Origin Scale. GSI=General Severity Index of the SCL-90R.
MFSI=Multidimensional Fatigue Symptom Inventory.
Table 3.1
Intercorrelations Between Major Independent Variables with Dependent Variables for the Muscle Pain Patients. (N = 22)

Measure

1. LF/HF-B
2. LF/HF-R
3. PSQI
4. SCS
5. DUKE
6. ERQ-R
7. ERQ-S
8. FOS
9. GSI
MFSI
10. General
11. Emotion
12. Physical
13. Mental
14. Vigor

1

2

3

4

5

6

7

8

9

1.0
.244
-.112
.458
-.449
-.443
-.019
-.245
.205

1.0
-.118
.035
-.081
-.065
.144
.278
.160

1.0
.232
.035
-.097
.006
.013
.343

1.0
-.689*
-.313
.349
-.476
.539*

1.0
.427
-.351
.565*
-.556*

1.0
-.117
.259
.357

1.0
.130
.495*

1.0
-.300

1.0

.006
.136
-.105
.176
-.156

.202
.155
-.005
.465
.039

.454
.352
-.126
.257
.228

.174
.376
.213
.198
-.176

-.174
-.353
-.157
-.415
.554*

-.226
-.156
-.190
-.279
.297

.460*
-.055
.385
.554*
-.234

.070
-.349
-.053
-.088
.140

.682*
.545*
.490
.658*
-.381

10

11

12

13

1.0
.412
.397
.789*
.018

1.0
.112
.310
-.095

1.0
.191
-.175

1.0
-.068

22

* correlation is significant at the .01 level.
Note. LF/HF=Low Frequency to High Frequency HRV Ratio (B=Baseline, R=Recovery). VAS=Visual Analog Scale of
present pain. Duration=Duration of pain. PSQI=Pittsburgh Sleep Quality Index. SCS=Social Constraints Scale. DUKE-SSQ:
Duke Social Support Questionnaire. ERQ-R=Emotion Regulation Questionnaire-Reappraisal. ERQ-S=Emotion Regulation
Questionnaire-Suppression. FOS=Family of Origin Scale. GSI=General Severity Index of the SCL-90R.
MFSI=Multidimensional Fatigue Symptom Inventory.
Table 3.2
Intercorrelations Between Major Independent Variables with Dependent Variables for the Pain Free Controls. (N = 23)

Table 3.3
Characteristics of Heart Rate Variability Indices

Pain

Group Control Group

F(1,44)

p

Cohen’s d

(n=22)

(n=23)

M (sd)

M (sd)

60.11

51.18

3.86

.056

.59

(17.92)
39.89

(11.89)
48.82

3.86

.056

.59

(17.92)
1.97

(11.89)
1.16

9.17

.004

.90

(1.16)

(.52)

74.65

73.83

.04

.843

.06

(14.80)
24.44

(12.36)
26.17

.22

.646

.14

(12.27)
4.40

(12.36)
3.76

.53

.470

.16

(3 37)

(2 36)

63.87

54.69

4.30

.044

.62

(16.61)
36.13

(12.66)
46.49

6.11

.018

.74

(16.61)
2.72

(10.82)
1.26

6.47

.015

.75

Baseline
LF (nu)
HF (nu)
LF/HF
Recall
LF (nu)
HF (nu)
LF/HF
Recovery
LF (nu)
HF (nu)
LF/HF

(2 71)
( 49)
Note. LF (nu) = Low Frequency (normalized units), HF (nu) = High Frequency
(normalized units), LF/HF = Low Frequency to High Frequency ratio. Cohen’s d notes
effect sizes for significant contrasts.
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Table 3.4
ANCOVA Results for Heart Rate Variability Indices
Pain Group
(n=22)
M (sd)

Control Group
(n=23)
M (sd)

F(1,44)

P

LF (nu)

74.65
(14.80)

73.83
(12.36)

.07

.793

HF (nu)

24.44
(12.27)

26.17
(12.36)

.00

.985

LF/HF

4.40
(3.37)

3.76
(2.36)

.00

.987

LF (nu)

63.87
(16.61)

54.69
(12.66)

1.02

.318

HF (nu)

36.13
(16.61)

46.49
(10.82)

2.26

.140

Recall

Recovery

2.72
1.26
1.07
.308
(2.71)
(.49)
Note. Baseline values for HRV indices were used as covariates for these data. LF (nu) =
Low Frequency (normalized units), HF (nu) = High Frequency (normalized units), LF/HF
= Low Frequency to High Frequency ratio.
LF/HF
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Table 3.5
Characteristics of Heart Rate Variability Indices in MMP Patients Reporting a Trauma

Baseline

Recall

Recovery

LF (nu)

59.15a
(18.27)

77.18 b
(13.43)

64.37 b
(17.25)

HF (nu)

40.85 a
(18.28)

22.81 b
(13.43)

35.63 b
(17.25)

LF/HF

1.91 a
(1.19)

5.17 b
(4.01)

3.07 b
(3.33)

MMP reporting
a trauma
(n=14)

Note. Means and standard deviations are shown. LF (nu) = Low Frequency (normalized
units), HF (nu) = High Frequency (normalized units), LF/HF = Low Frequency to High
Frequency ratio.
ab
When superscripts are the same between the periods on a measure, focused contrasts
indicate no significant difference in period means. When superscripts are different,
focused contrasts indicate significant difference between period means at p < .05.
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Table 3.6
SCL-90-R Symptom Dimension, Fatigue, and Sleep Quality Means and Standard
Deviations

General Severity
Index (GSI)
Somatization
Obsessivecompulsive
Interpersonal
Sensitivity
Depression
Anxiety
Hostility
Phobic anxiety
Paranoid
ideation
Psychoticism

Pain Group
(n=22)
M (sd)
64.55
(6.89)
67.95
(7.56)
63.23
(10.56)
58.73
(9.07)
63.36
(5.67)
59.14
(11.13)
55.91
(10.46)
56.09
(11.75)
57.41
(11.48)
59.09
(11.45)

Control Group
(n=23)
M (sd)
54.26
(9.69)
50.48
(9.78)
54.39
(11.24)
56.78
(11.55)
56.04
(9.32)
50.48
(10.02)
50.91
(7.12)
50.87
(8.77)
50.43
(11.79)
55.74
(11.56)

MFSI
General
Fatigue
Emotional
Fatigue
Physical
Fatigue
Mental
Fatigue
Vigor

F(1,44)

p

Cohen’s d

16.69

.001

1.22

44.71

.001

2.00

7.74

.009

.81

.39

.534

.19

10.03

.003

.95

7.54

.009

.82

3.54

.067

.56

2.87

.097

.80

4.03

.051

.60

.95

.334

.29

16.77
6.68
13.56
.001
1.22
(8.96)
(7.52)
9.91
6.96
3.27
.077
.54
(5.99)
(4.90)
11.95
6.73
32.99
.001
1.74
(3.22)
(2.76)
8.59
3.65
12.87
.001
1.01
(5.37)
(3.76)
8.91
12.91
11.72
.001
1.02
(4.45)
(3.34)
PSQI
11.36
4.70
56.88
.001
2.00
(3.54)
(2.29)
Note. SCL-90-R = Symptom CheckList 90 – Revised, MFSI = Multidimensional Fatigue
Symptom Inventory, PSQI = Pittsburgh Sleep Quality Index.
Cohen’s d notes effect sizes for significant contrasts.
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Table 3.7
Characteristics of Self-Report Psycho-Social Domain Measures
Pain Group
(n=22)
M (sd)
34.33
(11.95)

Control Group
(n=23)
M (sd)
26.00
(9.26)

F(1,44)

p

Cohen’s d

7.40

.009

.78

DUKE-SSQ

30.62
(7.05)

31.27
(8.19)

.08

.779

.09

Family of Origin

42.48
(12.58)

50.09
(11.32)

4.46

.041

.65

ERQReappraisal

31.33
(5.20)

29.65
(5.84)

.93

.341

.30

Measure
SCS

ERQ12.86
12.35
.04
.851
.12
Suppression
(3.77)
(4.67)
Note. PSQI = Pittsburgh Sleep Quality Index, SCS = Social Constraints Scale, DUKESSQ – DUKE Social Support Questionnaire, ERQ = Emotion Regulation Questionnaire,
MFSI = Multidimensional Fatigue Symptom Inventory. Cohen’s d notes effect sizes for
significant contrasts.
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Figure 3.1
Low Frequency (nu) HRV
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Note: *p<.06 between group comparison marginally significant at the baseline period.
**p<.05 between group comparison significant at the recovery period.
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Figure 3.2
High Frequency (nu) HRV
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Note: *p<.06 between group comparison marginally significant at the baseline period.
**p<.05 between group comparison significant at the recovery period.
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Figure 3.3
Low Frequency to High Frequency Ratio (LF/HF)
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Chapter 4
Discussion
This study compared a group of chronic masticatory muscle pain patients with a
group of age, height, and weight matched pain-free controls on emotional and
physiological reactivity to a personally relevant stressor. The main aim of this study was
to determine the efficacy of using heart rate variability indices as quantitative measures
of autonomic regulation that would differentiate chronic masticatory muscle pain patients
from matched pain-free controls. One of the noteworthy findings from this study was
that muscle pain patients showed significantly higher LF, LF/HF ratio, and lower HF
HRV indices during recovery from a personally relevant stressor compared to the painfree controls. During the stressor period the HRV index values were nearly the same for
both study groups.
The physiological differences shown by the HRV indices between muscle pain
patients and pain-free controls during the recovery period helps us understand previous
findings of heightened physiological activation with these patients. Masticatory muscle
pain patients have shown more cardiovascular and emotional reactivity to a standard
stressor when compared to controls (Carlson et al., 1998; Curran et al., 1996). Muscle
pain patients have also consistently shown lower pain threshold and tolerance when
compared to pain-free controls (Carlson et al., 1998; Maixner et al., 1995; Maixner,
Fillingim, Sigurdsson, Kincaid, & Silva, 1998). While pain-sensitivity differences are
likely due to a complex integration of central nervous system changes, these differences
also could be linked to chronic physiological activation that does not respond to
inhibitory controls. The HRV differences between muscle pain patients and pain-free
controls in the present study suggest potential use of HRV indices as a means to study the
relative contributions of sympathetic and parasympathetic activity. Furthermore, the
nearly significant increased sympathetic activity and decreased parasympathetic activity
noted in the muscle pain patients at rest in this study as compared to the pain-free
controls raises the possibility that these patients may be experiencing compromised
inhibitory control of sympathetic activity.
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Heart rate variability as an index of autonomically-mediated inhibitory control is
central to Thayer’s model of neurovisceral integration (Thayer & Lane, 2000). Within
the framework of this model, Thayer proposed that the measurement of HRV may
quantify self-regulatory ability. Specifically, higher vagal tone as indexed by higher HF
HRV is associated with enhanced self-regulatory ability through greater behavioral
flexibility and adaptability. Poor HRV, as indexed by higher LF and lower HF HRV, is
associated with poor self-regulation and a lack of behavioral flexibility (Porges, 1992;
Thayer & Lane, 2000). Thayer’s model posits that a reduction in overall system
flexibility results from disinhibition of sympathetic nervous system activity. The data
presented here provide evidence of such sympathetic disinhibition in chronic muscle pain
patients. Higher LF and lower HF index values in the muscle pain patients during the
baseline and recovery periods compared to pain-free controls suggest diminished
inhibitory control both at rest and after a stressor. This pattern of physiological activation
indexed by HRV measures has been associated with not only other chronic pain
conditions, but other negative life experiences as well (Thayer & Lane, 2002).
It is not surprising, therefore, that patients reporting a traumatic stressor could not inhibit
sympathetic activation during the recovery period. As we hypothesized, the HRV values
during the recovery period were similar to HRV values during the stressor period for
these patients. The high LF and low HF HRV index values in this group of muscle pain
patients during recovery suggest an inability to inhibit sympathetic activity. Previous
studies exploring hyperarousal in PTSD patients also have demonstrated a basal state of
autonomic activation characterized by pronounced sympathetic activity, followed by no
significant inhibitory activity of sympathetic tone after recounting traumatic events or
after discussion of the traumatic experience linked to the onset of PTSD (Cohen et al.,
2000; Cohen et al., 1998). The lack of variability in autonomic activity in PTSD patients
in these studies suggests a prolonged activation of the sympathetic nervous system.
Although the muscle pain patients reporting a traumatic experience in the present study
did respond to discussing the event with an increase in LF and a decrease in HF HRV
indices, these patients also had sustained physiological arousal between the stressor and
recovery periods. The differences between results found by Cohen and the present study
may be due mainly to patient characteristics. The patient volunteers in Cohen’s studies
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were all diagnostically classified with PTSD and were being treated on an outpatient
basis for this disorder. In contrast, only 23% of the patients reporting a traumatic event in
this study met the cut-off for clinically significant PTSD symptomatology. Thus it is not
surprising that physiological activation in the muscle pain patients was not as pronounced
as is found in those with a diagnosis of PTSD.
The HRV characteristics of the muscle pain patients across study periods suggest
the problem is not in reaction to a stressor per se, but more likely a problem of prolonged
sympathetic activation stemming from inhibitory failure, or a failure of recovery
following exposure to stressors. Since the muscle pain patients also reported more
anxiety after the baseline period and more anger after the recovery period compared to
the pain-free controls, it may be that emotional reactivity is contributing to the elevated
level of physiological functioning found in the muscle pain patients as compared to the
pain-free controls. The presence of more emotional reactivity in the muscle pain patients
suggests that emotion regulation may be a factor. These results are in contrast to Carlson
et al (1998), who did not report any differences on emotional reactivity between
masticatory muscle pain patients and matched controls at baseline or after a standard
stressor. On the other hand, use of a personally relevant stressor, in this case discussing a
distressing or traumatic life experience, may account for this difference. While the
change in HRV indices between the baseline and recall periods for both the muscle pain
patients and the pain-free controls indicate the emotional stressor did in fact significantly
influence autonomic system functioning through emotional arousal, the patients reported
more emotional reactivity both prior to and after the stressor. In Thayer’s model of
neurovisceral integration (Thayer & Lane, 2000), the inability to inhibit sympathetic
activity has been associated with a defensive attentional style characteristic of anxiety,
hyperarousal, and poor emotion regulation capabilities. These characteristics may also be
present to some degree in chronic muscle pain patients and be contributing to the
prolonged physiological activation.
Consistent with previous literature focused on psychological distress in muscle
pain patients, the SCL-90 results also suggest a problem with persistent emotional
turmoil and poor emotional processing. The psychological distress in these patients may
be the result of an emotion regulation deficiency, pre-morbid psychopathology, a long-
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term problem due to an antagonistic and unloving family-of-origin environment, or a
combination thereof. Regardless of the source, problems in the social environment, as
shown by the presence of social constraints in the muscle pain patients, suggests
insufficient opportunities for cognitive processing of distress-related information. This is
consistent with social-cognitive processing theory (Lepore, 2001; Lepore & Helgeson,
1998) which posits that trauma-related distress may remain elevated if the individual fails
to engage in suitable discussion of thoughts and feelings regarding the traumatic
experience. Such failure may occur due to the lack of ability to express trauma-related
thoughts and feelings (e.g., alexithymia). A failure to discuss trauma-related thoughts
and feelings may also be due to a social environment that is constraining, where the
individual’s attempts at discussion are met with unexpected or negative responses from
others. Discussion and processing of trauma-related thoughts and feelings in a nonconstraining social environment, on the other hand, provides opportunities for the
individual to confront and reevaluate thoughts and feelings so that this information can be
integrated into preexisting mental schemas.
There is conflicting evidence in the literature about the etiology and mechanisms
involved in maintenance of muscle pain conditions. For example, some evidence
suggests alterations in central processing structures maintain these conditions (Maixner et
al., 1995; Maixner, Fillingim, Kincaid, Sigurdsson, & Harris, 1997; Maixner et al., 1998).
This central nervous system change may be due to alterations in baroreceptor effects,
which in turn are influenced by arterial blood pressure changes (Maixner et al., 1998).
There is also evidence to support the pain-adaptation model (Graven-Nielsen, Svensson,
& Arendt-Nielsen, 1997), which proposes chronic pain arises from increases in muscle
activity in antagonist musculature structures. This increase in antagonist muscle
structures is likely a functional adaptation of muscle coordination to limit muscle activity
at the site of pain (Lund, 1991). In general, however, the evidence that over-activation of
muscle structures as a driving mechanism for chronic muscle pain is not consistent
(Ohrbach & Dworkin, 1998). The present study suggests that a failure of inhibitory
control of sympathetic activation may be influencing central processing, as well as
physiological changes in peripheral structures.

34

The data presented here suggest the use of HRV frequency analyses can be
helpful in identifying muscle pain patients with chronic autonomic arousal. The HRV
indices are consistent and stable biomarkers for sympathetic activation and inhibitory
failure. More importantly, HRV frequency indices demonstrate the ability to differentiate
among muscle pain patients with traumatic experiences and those without such
experiences. There is also potential application of these quantitative markers for
evaluating the effects of the treatment of chronic masticatory muscle pain patients.
Techniques that conceivably strengthen sympathetic inhibitory control through increasing
vagal tone should lead to an improvement in HRV indices, increased parasympathetic
tone, improved inhibition of sympathetic activation, and possible changes in
psychophysiological response to environmental challenge. Carlson and colleagues have
developed a Physical Self-Regulation Training protocol for chronic orofacial pain
patients that includes components tailored to reduce physiological activation through the
use of diaphragmatic breathing training, gentle stretching exercises, and proprioceptive
awareness training (Carlson, Bertrand, Ehrlich, Maxwell, & Burton, 2001). While the
effect of these interventions on HRV indices have yet to be evaluated, the physiological
activation differences between the muscle pain patients and pain-free controls in the
present study suggest such self-regulatory skills training improves inhibitory control of
sympathetic activity. Indeed, recent work by Lehrer and colleagues has shown that
biofeedback training using HRV indices resulted in increased vagal tone and
parasympathetic arousal as well as an increase in baroreflex gain (Lehrer et al., 2003).

Limitations
While the results of this study are potentially very important, several limitations
must be noted. Although the experimental design lays the essential foundation for
determining between-group differences, nearly significant baseline group differences on
the HRV indices make it difficult to establish definitively the problem of recovery after
the stressor. Recovery from events that provoke sympathetic activity in pain patients thus
remains an open question that requires further study. Additionally, the sample size in this
study is small and only includes women. There is also evidence of gender differences in
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HRV measures (Carter et al., 2003). These limitations suggest the need for replication of
this study, and broader evaluation of HRV characteristics in orofacial pain patients.
The Emotion Regulation Questionnaire did not demonstrate differences between
the groups on the emotion regulation strategies of suppression or reappraisal. This result
may be due to no differences between the groups on these emotion regulation strategies.
However, it may also be due to a measurement issue with this population or with the selfreport instrument itself. The psychological data in this study and in previous studies
suggest that emotion regulation is an important issue for MMP patients. Future studies
should consider more focused measures of emotion regulation to investigate associations
between that construct and other characteristics of patients with orofacial pain conditions.

Summary
In summary, the present study provides evidence of physiological activation and
emotional responding to a personally-relevant stressor in masticatory muscle pain
patients that differentiates them from matched pain-free controls. The use of HRV
indices to measure physiological functioning quantifies the degree of sympathetic and
parasympathetic activity. The results suggest the use of these HRV indices will improve
understanding of the role that excitatory and inhibitory mechanisms play in the onset and
maintenance of chronic masticatory muscle pain conditions.
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Appendix
Pittsburgh Sleep Quality Index (PSQI)
Name__________________________ ID#_________ Date________ Age___________
Instructions:
The following questions relate to your usual sleep habits during the past month ONLY. Your
answers should indicate the most accurate reply for the majority of days and nights in the past
month. Please answer all questions.
1. During the past month, when have you usually gone to bed at night?
USUAL BED TIME_________________________
2. During the past month, how long (in minutes) has it usually taken you to fall asleep each
night?
NUMBER OF MINUTES_____________________
3. During the past month, when have you usually gotten up in the morning?
USUAL GETTING UP TIME__________________
4. During the past month, how many hours of actual sleep did you get at night? (This may
be different than the number of hours you spend in bed.)
HOURS OF SLEEP PER NIGHT________________
For each of the remaining questions, check the one best response. Please answer all questions.
5. During the past month, how often have you had trouble sleeping because you……..
(a) cannot get to sleep within 30 minutes
Not during the Less than Once or Three or more
past month________ once a week_______ twice a week_______ times a week______
(b) Wake up in the middle of the night or early morning
Not during the Less than Once or Three or more
past month________ once a week_______ twice a week_______ times a week______
(c) Have to get up to use the bathroom.
Not during the Less than Once or Three or more
past month________ once a week_______ twice a week_______ times a week______
(d) Cannot breathe comfortably.
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Not during the Less than Once or Three or more
past month________ once a week_______ twice a week_______ times a week______
(e) Cough or snore loudly.
Not during the Less than Once or Three or more
past month________ once a week_______ twice a week_______ times a week______
(f) Feel too cold.
Not during the Less than Once or Three or more
past month________ once a week_______ twice a week_______ times a week______
(g) Feel too hot.
Not during the Less than Once or Three or more
Past month________ once a week_______ twice a week_______ times a week______
(h) Had bad dreams.
Not during the Less than Once or Three or more
Past month________ once a week_______ twice a week_______ times a week______
(i) Have pain.
Not during the Less than Once or Three or more
Past month________ once a week_______ twice a week_______ times a week______
(j) Other reason(s), please describe_____________________________________

page
How often during the past month have you had trouble sleeping because of this?
Not during the Less than Once or Three or more
Past month________ once a week_______ twice a week_______ times a week______
6. During the past month, how would you rate your sleep quality overall?
Very good _____________
Fairly good _____________
Fairly bad _____________
Very bad _____________
7. During the past month, how often have you taken medicine (Prescribed or "over the
counter") to help you sleep?
Not during the Less than Once or Three or more
Past month________ once a week_______ twice a week_______ times a week______
8. During the past month, how often have you had trouble staying awake while driving,
eating meals, or engaging in social activity?

39

Not during the Less than Once or Three or more
Past month________ once a week_______ twice a week_______ times a week______
9. During the past month, how much of a problem has it been for you to keep up enough
enthusiasm to get things done?
No problem at all _________
Only a very slight problem _________
Somewhat of a problem _________
A very big problem _________
10. Do you have a bed partner or share a room?
No bed partner or do not share a room _________
Partner/ flatmate in other room _________
Partner in same room, but not same bed _________
Partner in same bed _________
11. If you have a bed partner or share a room, ask him/her how often in the past month you
have had………
(a) Loud snoring.
Not during the Less than Once or Three or more
Past month________ once a week_______ twice a week_______ times a week______
(b) Long pauses between breaths while asleep.
Not during the Less than Once or Three or more
Past month________ once a week_______ twice a week_______ times a week______
(c) Legs twitching or jerking while you sleep.
Not during the Less than Once or Three or more
Past month________ once a week_______ twice a week_______ times a week______
(d) Episodes of disorientation or confusion during sleep.
Not during the Less than Once or Three or more
Past month________ once a week_______ twice a week_______ times a week______
(e) Other restlessness while you sleep: please describe_________________________
______________________________________________________________________________
Not during the Less than Once or Three or more
Past month________ once a week_______ twice a week_______ times a week______
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Posttraumatic stress disorder Check List – Civilian version (PCL-C)
Sometimes things happen to people that are stressful or disturbing – events that involve
experiencing or witnessing actual or threatened death or serious injury to oneself or
others. These events may cause the person to feel intense, fear, helplessness, or horror.
These include earthquakes, very serious accidents or fires, physical assault or rape, being
mugged or robbed, being physically or sexually abused, seeing other people killed or
dead, being in a war or heavy combat, being diagnosed with a life-threatening illness or
some other type of disaster.
Have any of these or other kinds of things happened to you?
Yes
No
Please check each relevant item on the list below.
















Military combat
Violent attack (robbery, mugging, sexual/physical assault)
Being kidnapped
Taken hostage
Terrorist attack
Torture
Incarceration (POW, Concentration camp)
Natural or man-made disaster
Severe auto accident
Being diagnosed with a life-threatening illness
Sudden injury/serious accident
Observed someone hurt or killed
Learned about family member or close friend hurt or killed
Learned your child has a life-threatening illness
Other (Please describe)

Please write the item from the above list that has been YOUR MOST SIGNIFICANT
STRESSOR here:

Please enter the month and year the stressor occurred:
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Please complete the following questions with reference to YOUR MOST SIGNIFICANT
STRESSOR.
Below is a list of problems and complaints that people sometimes have in response to
stressful experiences. Please read each one carefully, then circle one of the numbers to
indicate how much you have been bothered by that problem in the past month.
1. Repeated, disturbing memories, thoughts or images of a stressful experience?
1
Not at all

2
A little bit

3
Moderately

4
Quite a bit

5
Extremely

2. Repeated, disturbing dreams of a stressful experience?
1
Not at all

2
A little bit

3
Moderately

4
Quite a bit

5
Extremely

3. Suddenly acting or feeling as if a stressful experience were happening again (as if you
were reliving it)?
1
Not at all

2
A little bit

3
Moderately

4
Quite a bit

5
Extremely

4. Feeling very upset when something reminded you of a stressful experience?
1
Not at all

2
A little bit

3
Moderately

4
Quite a bit

5
Extremely

5. Having physical reactions (e.g., heart pounding, trouble breathing, sweating) when
something reminded you of a stressful experience?
1
Not at all

2
A little bit

3
Moderately

4
Quite a bit

5
Extremely

6. Avoiding thinking about or talking about of a stressful experience or avoiding having
feelings related to it?
1
Not at all

2
A little bit

3
Moderately

4
Quite a bit

5
Extremely

7. Avoiding activities or situations because they reminded you of a stressful experience?
1
Not at all

2
A little bit

3
Moderately
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4
Quite a bit

5
Extremely

8. Trouble remembering important parts of a stressful experience?
1
Not at all

2
A little bit

3
Moderately

4
Quite a bit

5
Extremely

4
Quite a bit

5
Extremely

4
Quite a bit

5
Extremely

9. Loss of interest in activities you used to enjoy?
1
Not at all

2
A little bit

3
Moderately

10. Feeling distant or cut off from other people?
1
Not at all

2
A little bit

3
Moderately

11. Feeling emotionally numb or being unable to have loving feelings for those close to
you?
1
Not at all

2
A little bit

3
Moderately

4
Quite a bit

5
Extremely

12. Feeling as if your future somehow will be cut short?
1
Not at all

2
A little bit

3
Moderately

4
Quite a bit

5
Extremely

4
Quite a bit

5
Extremely

3
Moderately

4
Quite a bit

5
Extremely

3
Moderately

4
Quite a bit

5
Extremely

4
Quite a bit

5
Extremely

13. Trouble falling or staying asleep?
1
Not at all

2
A little bit

3
Moderately

14. Feeling irritable or having angry outbursts?
1
Not at all

2
A little bit

15. Having difficulty concentrating?
1
Not at all

2
A little bit

16. Being “superalert” or watchful or on guard?
1
Not at all

2
A little bit

3
Moderately
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17. Feeling jumpy or easily startled?
1
Not at all

2
A little bit

3
Moderately

4
Quite a bit

5
Extremely

In response to the YOUR MOST SIGNIFICANT STRESSOR have you…
Reacted with feelings of intense fear, helplessness, or horror?

YES or NO

Felt that the event was a potential threat to your life and safety or the lives and safety of
others? YES or NO
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Multi-dimensional Fatigue Symptom Inventory (MFSI).
Below is a list of statements that describe how people sometimes feel. Please read each
item carefully, then circle the one number next to each item which best describes how
true each statement has been for you in the past 7 days.
Not at all

A little

Moderately

Quite a bit

Extremely

1.

I have trouble remembering things

0

1

2

3

4

2.

My muscles ache

0

1

2

3

4

3.

I feel upset

0

1

2

3

4

4.

My legs feel weak

0

1

2

3

4

5.

I feel cheerful

0

1

2

3

4

6.

My head feels heavy

0

1

2

3

4

7.

I feel lively

0

1

2

3

4

8.

I feel nervous

0

1

2

3

4

9.

I feel relaxed

0

1

2

3

4

10.

I feel pooped

0

1

2

3

4

11.

I am confused

0

1

2

3

4

12.

I am worn out

0

1

2

3

4

13.

I feel sad

0

1

2

3

4

14.

I feel fatigued

0

1

2

3

4

15.

I have trouble paying attention

0

1

2

3

4

16.

My arms feel weak

0

1

2

3

4

17.

I feel sluggish

0

1

2

3

4

45

18.

I feel run down

0

1

2

3

4

19.

I ache all over

0

1

2

3

4

20.

I am unable to concentrate

0

1

2

3

4

21.

I feel depressed

0

1

2

3

4

22.

I feel refreshed

0

1

2

3

4

23.

I feel tense

0

1

2

3

4

24.

I feel energetic

0

1

2

3

4

25.

I make more mistakes than usual

0

1

2

3

4

26.

My body feels heavy all over

0

1

2

3

4

27.

I am forgetful

0

1

2

3

4

28.

I feel tired

0

1

2

3

4

29.

I feel calm

0

1

2

3

4

30.

I am distressed

0

1

2

3

4
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Emotion Regulation Questionnaire (ERQ)
We would like to ask you some questions about your emotional life, in particular, how
you control (that is, regulate and manage) your emotions. We are interested in two
aspects of your emotional life. One is your emotional experience, or what you feel like
inside. The other is your emotional expression, or how you show your emotions in the
way you talk, gesture, or behave. Although some of the following questions may seem
similar to one another, they differ in important ways. For each item, please answer using
the following scale:
1-----------------2------------------3------------------4------------------5------------------6------------------7
strongly
neutral
strongly
disagree
agree

1. ____ When I want to feel more positive emotion (such as joy or amusement), I change
what I’m thinking about.
2. ____ I keep my emotions to myself.
3. ____ When I want to feel less negative emotion (such as sadness or anger), I change
what I’m thinking about.
4. ____ When I am feeling positive emotions, I am careful not to express them.
5. ____ When I’m faced with a stressful situation, I make myself think about it in a way
that helps me stay calm.
6. ____ I control my emotions by not expressing them.
7. ____ When I want to feel more positive emotion, I change the way I’m thinking about
the situation.
8. ____ I control my emotions by changing the way I think about the situation I’m in.
9. ____ When I am feeling negative emotions, I make sure not to express them.
10. ____ When I want to feel less negative emotion, I change the way I’m thinking about
the situation.
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Emotion Assessment Scale (EAS)
For each word listed, place a slash (/) somewhere on the appropriate line to indicate how
you are feeling at this moment.
Least Possible
1.

Surprised

2.

Afraid

3.

Disgusted

4.

Angry

5.

Guilty

6.

Anxious

7.

Sad

8.

Delighted

9.

Scared

10.

Astonished

11.

Repulsed

12.

Mad

13.

Ashamed

14.

Worried

15.

Disturbed

16.

Joyful

17.

Frightened

18.

Amazed

19.

Sickened

20.

Annoyed

21.

Humiliated

22.

Nervous

23.

Hopeless

24.

Happy

Most Possible
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Family of Origin Scale – short form (FOS)
Instructions:
Using the scale below as a guide, write a number besides each statement to indicate how
much you agree with it.
Strongly
disagree
1

Disagree

Neutral

Agree

2

3

4

Strongly
Agree
5

_________ In my family, we encouraged each other to develop new friendships.
_________ Conflicts in my family never got resolved.
I found it difficult to understand what other family members said and how
_________ they felt.
_________ In my family, I expressed just about any feeling I had.
My family was receptive to the different ways various family members
_________ viewed life.
I often had to guess at what other family members thought or how they
_________ felt.
_________ My family members rarely expressed responsibility for their actions.
Sometimes in my family I did not have to say anything, but felt
_________ understood.
I found it easy to understand what other family members said and how
_________ they felt.
_________ I found it difficult to express my own opinions in my family.
_________ In my family, no one cared about the feelings of other family members.
_________ In my family, certain feelings were not allowed to be expressed.
_________ My family members usually were sensitive to one another’s feelings.
_________ In my family, people took responsibility for what they did.
_________ I remember my family as being warm and supportive.
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SCS
Below is a list of social experiences. For each question, please circle a number of how
often you have had that experience in the past month.
How often in the past month did your
friends or family…
change the subject when you tried to discuss
1.
your problems?

Never

Rarely

Someti
mes

Often

1

2

3

4

2.

not seem to understand your situation?

1

2

3

4

3.

avoid you?

1

2

3

4

4.

minimize your problems?

1

2

3

4

5.

seem to be hiding their feelings?

1

2

3

4

1

2

3

4

6.

act uncomfortable when you talked about your
problems?

7.

trivialize your problems?

1

2

3

4

8.

complain about their own problems when you
wanted to share yours?

1

2

3

4

9.

act cheerful around you to hide their true
feelings or concerns?

1

2

3

4

10.

tell you not to worry so much about your
health?

1

2

3

4

11.

tell you to try not to think about your
problems?

1

2

3

4

12.

give you the idea that they didn’t want to hear
about your problems?

1

2

3

4

13.

make you feel as though you had to keep your
feelings about your problems to yourself,
because they made them feel uncomfortable?

1

2

3

4

14.

make you feel as though you had to keep your
feelings about your problems to yourself,
because they made them feel upset?

1

2

3

4

15.

let you down by not showing you as much love
and concern as you would have liked?

1

2

3

4
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DUKE-SSQ
Below is a list of things that other people do for us or give us that may be helpful or
supportive. Please read each statement carefully and indicate an answer that is closest to
your situation. Respond to each question by picking a number on the scale from “1” to
“5” to tell me how you feel about the amount of support you receive. Answering “1”
would mean that you get that type of support “much less than you would like” and
answering “5” would mean that you get that type of support “as much as you would like.”
Answering with numbers 2, 3, and 4 would indicate that you feel somewhere in-between.
For example, if asked if you get enough vacation time, answering “4” means that you get
“almost” as much vacation time as you would like, but not quite as much as you would
like. Answer each item as best you can. There are no right or wrong answers.
As
much
as I
would
like

Much
less
than I
would
like

1.

I have people who care about what happens to
me.

1

2

3

4

5

2.

I get love and affection.

1

2

3

4

5

3.

I get chances to talk to someone about problems
at work or with my homework.

1

2

3

4

5

4.

I get chances to talk to someone I trust about my
personal and family problems.

1

2

3

4

5

5.

I get chances to talk about money matters.

1

2

3

4

5

6.

I get invitations to go out and do things with other
1
people.

2

3

4

5

7.

I get useful advice about important things in life.

1

2

3

4

5

8.

I get help when I’m sick in bed.

1

2

3

4

5
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